Profile

Public Health Agency of Canada

Profile for Public Health Agency of Canada. Every fact below is a verbatim quote from a real document we have stored. ↩ See the full Record

Relationships
funded EKOS Research
other OxyContin
other Pappin, Bavli, and Herder
other Xylazine
other Ontario
other Hamilton
other Ontario
other British Columbia
other OxyContin
other introduction of user fees
other BC Ministry
Established facts
  • Valerian Labs was Health Canada-licensed to manufacture natural health products · source
  • Health Canada began collecting user fees from pharmaceutical companies in 1994 ↗ · source
  • Health Canada was aware of the FDA action and treats the FDA as a reliable source of information for monitoring drugs for safety problems, specifically with regard to prescription drug abuse. ↗ · source
  • The agency relied on two internal drug-report searches in May and July 2001 that found no adverse drug reports involving OxyContin. ↗ · source
  • The 2006 revision merely added the word "usually" to the misleading claim — i.e., "Drug abuse is usually not a problem…" ↗ · source
  • expanded naloxone distribution as the single most likely factor in the modest 2024 mortality decline ↗ · source
  • Xylazine first appeared in Health Canada DAS samples in 2018 ↗ · source
  • OxyContin was approved by Health Canada in 1996 ↗ · source
Drawn from 5 source documents in the Library. Every attribute and relationship above traces back to a verbatim quote.